Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPensionProperty, Plant & Equipment (Net)Retained EarningsShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abivax (ABVX) Non-Current Debt (2022 - 2024)

Historic Non-Current Debt for Abivax (ABVX) over the last 4 years, with Q3 2025 value amounting to $4.9 million.

  • Abivax's Non-Current Debt changed N/A to $4.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.9 million, marking a year-over-year change of. This contributed to the annual value of $25.0 million for FY2024, which is 4184.32% down from last year.
  • According to the latest figures from Q3 2025, Abivax's Non-Current Debt is $4.9 million.
  • Abivax's 5-year Non-Current Debt high stood at $42.7 million for Q4 2023, and its period low was $4.9 million during Q3 2025.
  • For the 4-year period, Abivax's Non-Current Debt averaged around $24.0 million, with its median value being $25.1 million (2025).
  • As far as peak fluctuations go, Abivax's Non-Current Debt surged by 15776.71% in 2023, and later tumbled by 4153.09% in 2024.
  • Quarter analysis of 4 years shows Abivax's Non-Current Debt stood at $16.6 million in 2022, then soared by 157.77% to $42.7 million in 2023, then tumbled by 41.53% to $25.0 million in 2024, then tumbled by 80.48% to $4.9 million in 2025.
  • Its last three reported values are $4.9 million in Q3 2025, $27.4 million for Q2 2025, and $25.1 million during Q1 2025.